SOD1 and amyotrophic lateral sclerosis: Subsequently, another group reported using ALS patient cells carrying heterozygous mutations of SOD1+/A272C and FUS+/G1556A to generate iPSCs and used the CRISPR-Cas9 system along with single-stranded oligodeoxynucleotide (ssODN) to precisely correct these mutations [82].